Nanocomposite Inhibited Candida Albicans Growth

Researchers developed a ZnO-chitosan carrier for Matricaria chamomilla oil to target fungal biofilms.

Updated on Oct. 7, 2026 in Chemistry

Isometric editorial illustration of a complex, crystalline nanostructure representing a new antifungal material, set against a muted teal and cream background.
Researchers have synthesized a new zinc oxide-chitosan nanocomposite to deliver Matricaria chamomilla oil, potentially improving treatment for resistant Candida albicans infections. AI Illustration. Upload story photo >

Live Poll

Does new research on natural compounds increase your trust in the effectiveness of medical treatments?

Researchers have developed a zinc oxide-chitosan nanocomposite that successfully encapsulates Matricaria chamomilla essential oil. This research-stage antifungal system significantly inhibits the growth and biofilm formation of the fungus Candida albicans.

Why it matters

The development addresses the limited efficacy of conventional antifungal therapies by creating a targeted drug delivery system. It offers a potential path toward more effective treatments for fungal infections that have become increasingly resistant to standard medical protocols.

The nanocomposite features a mean particle size of 100 nm and an encapsulation efficiency of 75%. It achieved a Minimum Inhibitory Concentration (MIC) of 125 µg/mL and a Minimum Fungicidal Concentration (MFC) of 250 µg/mL against C. albicans.

The details

The team synthesized the material by combining zinc oxide (ZnO) and chitosan—a biopolymer derived from crustacean shells—to encapsulate the essential oil. Scientists characterized the structure using scanning electron microscopy (SEM) and X-ray diffraction (XRD) techniques. They assessed antifungal activity through CLSI broth microdilution assays, which measure the lowest concentration of an antimicrobial needed to inhibit visible growth, and verified the mechanical disruption of fungal cells using TEM imaging.

Timeline

  1. October 7, 2026: The research results were published.

The Tech Race

This study follows a growing trend of utilizing essential oils integrated with metallic nanoparticles to combat persistent microbial biofilms. It sits alongside ongoing efforts to replace or augment conventional antifungal drugs that are increasingly limited by fungal cellular adaptations.

This development is currently in the research stage and is not available for clinical or consumer use. Future progress will depend on further testing to determine if this nanocomposite remains safe and effective for use in humans against fungal pathogens.

The takeaway

This study demonstrates that combining natural extracts with inorganic nanoparticles can effectively disrupt fungal cell integrity. Researchers should watch for subsequent studies that assess potential toxicity in complex living systems beyond the L-929 fibroblast cell lines tested here.

Further reading

For broader research into material science and medicine, explore the latest findings in /Chemistry.

Source note: This article includes information reported by Nature.

Live Poll

Does new research on natural compounds increase your trust in the effectiveness of medical treatments?